Generate Biomedicines
Generate Biomedicines is a pioneering therapeutics company at the intersection of machine learning, biological engineering, and medicine. They are developing generative biology to create breakthrough medicines, fundamentally changing how medicines are made. Their platform can generate medicines on demand across multiple modalities with unprecedented speed and success rates, including antibodies, enzymes, and stealth proteins. The company is committed to responsible AI use and aims to radically transform drug discovery and development, leveraging AI, automation, and cutting-edge science to treat intractable diseases.
Industries
Nr. of Employees
medium (51-250)
Generate Biomedicines
Generate:Biomedicines, Somerville and Andover, Massachusetts
Patents
Products
Generative protein design platform (ML-driven generate–build–measure–learn loop)
An integrated platform that generates protein sequences computationally, synthesizes and tests them experimentally at scale, and uses resulting data to iteratively improve generative models.
Programmable generative model for proteins (research distribution)
Research-oriented generative model implementation and associated artifacts enabling sampling of novel protein structures, secondary-structure conditioned or symmetry-conditioned designs, and shape-conditioned proteins.
Generative protein design platform (ML-driven generate–build–measure–learn loop)
An integrated platform that generates protein sequences computationally, synthesizes and tests them experimentally at scale, and uses resulting data to iteratively improve generative models.
Programmable generative model for proteins (research distribution)
Research-oriented generative model implementation and associated artifacts enabling sampling of novel protein structures, secondary-structure conditioned or symmetry-conditioned designs, and shape-conditioned proteins.
Services
Computational generation of novel protein therapeutics followed by experimental build and measurement to produce candidates for preclinical and clinical development.
Multi-target collaborations with pharmaceutical companies and academic institutions to co-develop protein therapeutics using the generative platform.
Availability of generative model code, pre-trained weights, and browser-based interactive notebooks for research and reproducibility.
Computational generation of novel protein therapeutics followed by experimental build and measurement to produce candidates for preclinical and clinical development.
Multi-target collaborations with pharmaceutical companies and academic institutions to co-develop protein therapeutics using the generative platform.
Availability of generative model code, pre-trained weights, and browser-based interactive notebooks for research and reproducibility.
Expertise Areas
- Generative protein design
- Protein engineering and immunogenicity mitigation
- High-throughput structural biology
- Machine-learning driven drug discovery
Key Technologies
- Diffusion-based generative models for proteins
- Graph neural networks for molecular systems
- Equivariant neural layers for 3D structure synthesis
- Cryo-electron microscopy (cryoEM)
News & Updates
Announcement of new board member to strengthen leadership.
Company shares progress and future plans for AI-driven drug discovery.
Research on AI-designed antibodies for viral threats.
Highlighting contributions of women in AI and biology.
Announcement of new board member to strengthen leadership.
Company shares progress and future plans for AI-driven drug discovery.
Research on AI-designed antibodies for viral threats.
Highlighting contributions of women in AI and biology.